An open-label safety and drug interaction study of natalizumab (Antegren) in combination with interferon-beta (Avonex) in patients with multiple sclerosis (Q42637668)
Jump to navigation
Jump to search
scientific article published on October 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | An open-label safety and drug interaction study of natalizumab (Antegren) in combination with interferon-beta (Avonex) in patients with multiple sclerosis |
scientific article published on October 2004 |
Statements
1 reference
An open-label safety and drug interaction study of natalizumab (Antegren) in combination with interferon-beta (Avonex) in patients with multiple sclerosis (English)
1 reference
T L Vollmer
1 reference
J T Phillips
1 reference
A D Goodman
1 reference
M A Agius
1 reference
M A Libonati
1 reference
J L Giacchino
1 reference
J S Grundy
1 reference
1 October 2004
1 reference
1 reference
10
1 reference
5
1 reference
511-520
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference